UFP Technologies, Inc. (UFPT)
304.78
+4.08
(+1.36%)
USD |
NASDAQ |
Oct 05, 11:07
UFP Technologies EPS Diluted (Quarterly) : 2.677 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.677 |
| March 31, 2026 | 2.243 |
| December 31, 2025 | 2.250 |
| September 30, 2025 | 2.106 |
| June 30, 2025 | 2.210 |
| March 31, 2025 | 2.210 |
| December 31, 2024 | 2.101 |
| September 30, 2024 | 2.105 |
| June 30, 2024 | 1.748 |
| March 31, 2024 | 1.641 |
| December 31, 2023 | 1.505 |
| September 30, 2023 | 1.517 |
| June 30, 2023 | 1.545 |
| March 31, 2023 | 1.268 |
| December 31, 2022 | 1.100 |
| September 30, 2022 | 2.558 |
| June 30, 2022 | 1.174 |
| March 31, 2022 | 0.6367 |
| December 31, 2021 | 0.4214 |
| September 30, 2021 | 0.4988 |
| June 30, 2021 | 0.6226 |
| March 31, 2021 | 0.5499 |
| December 31, 2020 | 0.5508 |
| September 30, 2020 | 0.3955 |
| June 30, 2020 | 0.3078 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5162 |
| December 31, 2019 | 0.7657 |
| September 30, 2019 | 0.7528 |
| June 30, 2019 | 0.6158 |
| March 31, 2019 | 0.5001 |
| December 31, 2018 | 0.5908 |
| September 30, 2018 | 0.556 |
| June 30, 2018 | 0.5382 |
| March 31, 2018 | 0.2408 |
| December 31, 2017 | 0.3684 |
| September 30, 2017 | 0.23 |
| June 30, 2017 | 0.36 |
| March 31, 2017 | 0.30 |
| December 31, 2016 | 0.20 |
| September 30, 2016 | 0.37 |
| June 30, 2016 | 0.38 |
| March 31, 2016 | 0.15 |
| December 31, 2015 | 0.23 |
| September 30, 2015 | 0.28 |
| June 30, 2015 | 0.32 |
| March 31, 2015 | 0.23 |
| December 31, 2014 | 0.22 |
| September 30, 2014 | 0.29 |
| June 30, 2014 | 0.26 |
| March 31, 2014 | 0.29 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 1.103 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 20.85M |
| Revenue (Quarterly) | 173.96M |
| Total Expenses (Quarterly) | 153.11M |
| Enterprise Value | 2.456B |
| Gross Profit Margin (Quarterly) | 29.27% |
| Profit Margin (Quarterly) | 11.99% |
| Earnings Yield | 3.04% |
| Operating Earnings Yield | 4.05% |
| Normalized Earnings Yield | 3.038 |